# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-119748
Filing Date
2019-04-25
Accepted
2019-04-25 16:31:03
Documents
10
Period of Report
2019-06-10
Effectiveness Date
2019-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d713345ddef14a.htm | DEF 14A | 546283
2 | GRAPHIC | g713345g28m21.jpg | GRAPHIC | 115509
3 | GRAPHIC | g713345g32f32.jpg | GRAPHIC | 141557
4 | GRAPHIC | g713345g36g42.jpg | GRAPHIC | 28251
5 | GRAPHIC | g713345g39a84.jpg | GRAPHIC | 236571
6 | GRAPHIC | g713345g78t93.jpg | GRAPHIC | 172070
7 | GRAPHIC | g713345g92f71.jpg | GRAPHIC | 104610
8 | GRAPHIC | g713345g97o73.jpg | GRAPHIC | 58228
9 | GRAPHIC | g713345page011.jpg | GRAPHIC | 282258
10 | GRAPHIC | g713345page012.jpg | GRAPHIC | 147128
| Complete submission text file | 0001193125-19-119748.txt |  | 2320379

Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 19767862
SIC: 2836 Biological Products, (No Diagnostic Substances)